Canada markets open in 1 hour 46 minutes

Halozyme Therapeutics, Inc. (HALO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
40.37-0.49 (-1.20%)
At close: 04:00PM EDT
40.37 0.00 (0.00%)
After hours: 05:39PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close40.86
Open40.93
Bid40.29 x 800
Ask41.15 x 800
Day's Range40.32 - 40.96
52 Week Range29.85 - 45.00
Volume922,123
Avg. Volume1,412,645
Market Cap5.129B
Beta (5Y Monthly)1.25
PE Ratio (TTM)19.22
EPS (TTM)2.10
Earnings DateMay 07, 2024 - May 13, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est51.11
  • GuruFocus.com

    Insider Sell: SVP, Chief Technical Officer Michael Labarre Sells 20,000 Shares of Halozyme ...

    Halozyme Therapeutics Inc (NASDAQ:HALO), a biopharmaceutical company focused on developing and commercializing novel oncology therapies that target the tumor microenvironment, has reported an insider sell according to a recent SEC filing.

  • Insider Monkey

    Should You Hold Halozyme Therapeutics (HALO)?

    Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here. The portfolio had a positive absolute return in Q4 but underperformed the Russell 2000 Growth Index due to security selection, particularly in the healthcare and information technology sectors. In the […]

  • PR Newswire

    Halozyme to Participate in Upcoming Investor Conferences

    Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced that Dr. Helen Torley, president and chief executive officer, is scheduled to present and host investor meetings at the following investor conferences: